Takfa 0.5mg 10 Capsules

Babies: Not applicable. Lactating mothers: It is unsafe to use this medicine during breastfeeding. Studies have shown that the drug passes into the breastmilk and causes harm to the baby. Pregnancy: It is unsafe to use this medicine during pregnancy.
Studies have shown that the medicine causes harmful effects on the developing baby. Seek a doctor's advice before taking this medicine. Alcohol: It is unsafe to consume alcohol while taking this medicine. Driving: This medicine may cause dizziness, sleepiness and alters your ability to drive.
Do not drive if you experience these symptoms. Kidney: This medicine should be used with caution in patients with kidney disease.
Dose adjustment is required. Seek a doctor's advice before taking this medicine. Liver: This medicine should be used with caution in patients with liver diseases.
Studies have shown that dose adjustment is required in these patients. Seek a doctor's advice before using this medicine..

Nausea Stomach pain Diarrhea Liver damage Kidney damage Increased thirst Increased glucose levels in blood.

Takfa belongs to the class of immunosuppressants used in the prevention of organ rejection in transplant patients. It helps the body to accept the new organ and works by inhibiting the specific cells of the immune system..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine as prescribed by your doctor. • To get better results to take this medicine at a fixed time regularly. • Finish the entire course of this medicine. • Do not stop taking this medicine too early without consulting your doctor. • If you experience sore throat, bleeding, mouth ulcers, and fever while taking this medicine, inform your doctor..

Major • Takfa + Celecoxib: Concurrent use may lead to an increase in the risk of kidney damage • Takfa + Amiloride: Concurrent use may lead to an increase in the risk of hyperkalemia • Takfa + Efavirenz: Concurrent use may lead to an increase in the risk of irregular heart rhythm • Takfa + Fluconazole: Concurrent use may lead to an increase in the risk of hyperkalemia • Takfa + Bromfenac: Concurrent use may lead to an increase in the risk of kidney problems Moderate • Takfa + Albuterol: Concurrent use may lead to an increase in the risk of irregular heart rhythm • Takfa + Benazepril: Concurrent use may lead to an increase in the risk of hyperkalemia • Takfa + Formoterol: Concurrent use may lead to an increase in the risk of irregular heart rhythm • Takfa + Hydroxyzine: Concurrent use may lead to an increase in the risk of irregular heart rhythm • Takfa + Atorvastatin: Concurrent use may lead to an increase in the risk of muscle weakness and tenderness.